genprowebdirectory
Facebook
Linkedin
RSS
Twitter
Youtube
GEN Edge
Featured News
Multimedia
News
Insights
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Magazine
Browse Issues
Subscribe
Multimedia
Summits
Webinars
GEN Live
Learning Labs
Podcasts
Resources
A-Lists
eBooks/Perspectives
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Search
Facebook
Linkedin
RSS
Twitter
Youtube
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Privacy Policy
Password recovery
Recover your password
your email
A password will be e-mailed to you.
GEN – Genetic Engineering and Biotechnology News
GEN Edge
Featured News
Multimedia
News
Insights
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Magazine
Browse Issues
Subscribe
Multimedia
Summits
Webinars
GEN Live
Learning Labs
Podcasts
Resources
A-Lists
eBooks/Perspectives
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Home
2021
Hematologic diseases
Cancer
After Cancer Cases, Bluebird Bio Suspends Two Sickle Cell Trials
Drug Discovery
CRISPR Gene Editing Delivers Promise for Sickle-Cell Disease, Beta Thalassemia
Cancer
Potential Protein Protection for Kidneys from Cancer Therapies Discovered
Bioprocessing
AB2 Bio and WuXi Biologics Collaborate on Orphan Drug Manufacture
Drug Discovery
Astellas Takes AIRM Opening New Regenerative Medicine Institute in Massachusetts
Coronavirus
Massachusetts Biopharma Industry Weathers COVID-19 Impacts on Jobs, Financing
Bioprocessing
Orchard Therapeutics Inks Deal for GSK’s Stable Cell Line Technology
Drug Discovery
Gene-Editing Treatment CTX001 Shows Proof of Concept in TDT
News
RNA Probes Reveal Point Mutations, May Ease Detection of Disease Genes, Viral Strains
Bioprocessing
Sangamo CEO Looks Long-Term toward In Vivo Genome Editing, Regulation
1
...
5
6
7
...
29
Page 6 of 29
Scroll Up
Scroll Up
